Abstract: Methods for treating conditions associated with elevated, inappropriate or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an amylin agonist alone or in conjunction with other anti-gastric emptying agents. Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are also described.
Type:
Grant
Filed:
August 18, 2003
Date of Patent:
August 5, 2008
Assignee:
Amylin Pharmaceuticals, Inc.
Inventors:
Orville G. Kolterman, Andrew A. Young, Timothy J. Rink, Kathleen Ann Keating Brown
Abstract: Methods for affecting body composition include the use of amylin or amylin agonist(s). Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.
Type:
Grant
Filed:
May 20, 2004
Date of Patent:
July 15, 2008
Assignee:
Amylin Pharmaceuticals, Inc.
Inventors:
Christine Marie Mack, Jonathan David Roth